​

Cartesian Therapeutics Ownership | Who Owns Cartesian Therapeutics?

OverviewForecastRevenueFinancialsChart

Cartesian Therapeutics Ownership Summary

Cartesian Therapeutics is owned by 27.53% institutional investors, 53.68% insiders, and 18.78% retail investors. Squarepoint ops is the largest institutional shareholder, holding 8.62% of RNAC shares. Fidelity Select Health Care is the top mutual fund, with 1.42% of its assets in Cartesian Therapeutics shares.

RNAC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCartesian Therapeutics27.53%53.68%18.78%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Squarepoint ops2.24M8.62%$13.77M
Fmr799.74K3.08%$4.92M
Blackrock funding, inc. /de599.11K2.31%$3.68M
Vanguard group541.23K2.08%$3.90M
Bioimpact capital380.00K1.46%$3.88M
683 capital management330.00K1.27%$2.03M
Millennium management284.32K1.09%$1.75M
Geode capital management263.69K1.02%$1.62M
Marshall wace, llp251.12K0.97%$1.54M
Erste asset management gmbh221.71K0.85%$1.30M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bioimpact capital380.00K0.64%$3.88M
Privium fund management b.v.179.11K0.23%$1.10M
Miller financial services22.14K0.15%$136.18K
683 capital management330.00K0.11%$2.03M
Diametric capital, lp38.07K0.06%$234.12K
Virtus investment advisers11.11K0.03%$113.56K
Squarepoint ops2.24M0.02%$13.77M
Twin focus capital partners19.50K0.01%$119.92K
Erste asset management gmbh221.71K0.01%$1.30M
Ikarian capital20.81K0.01%$127.96K

Top Buyers

HolderShares% AssetsChange
Squarepoint ops2.24M0.02%2.22M
Millennium management284.32K0.00%119.95K
Aqr capital management84.02K0.00%84.02K
Two sigma investments, lp167.31K0.00%76.03K
Marshall wace, llp251.12K0.00%72.97K

Top Sellers

HolderShares% AssetsChange
Fmr799.74K0.00%-567.25K
Siren---563.27K
Bioimpact capital380.00K0.64%-306.01K
Gsa capital partners llp---77.23K
Erste asset management gmbh221.71K0.01%-50.00K

New Positions

HolderShares% AssetsChangeValue
Aqr capital management84.02K0.00%84.02K$516.72K
Vanguard fiduciary trust70.30K0.00%70.30K$432.32K
Diametric capital, lp38.07K0.06%38.07K$234.12K
Goldman sachs group30.93K-30.93K$190.20K
Man group23.70K0.00%23.70K$145.75K

Sold Out

HolderChange
Larson financial group-3.00
Truvestments capital-10.00
Coldstream capital management-29.00
National bank of canada /fi/-40.00
Spire wealth management-50.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20268115.71%7,151,13638.53%276.99%5541.03%14-17.65%
Dec 31, 202513-81.16%883,349-85.20%30.64%6-79.31%5-72.22%
Sep 30, 202523-62.90%695,491-88.85%20.46%7-75.00%9-47.06%
Jun 30, 202566-2.94%6,395,690-2.83%243.81%29-12.12%18-
Mar 31, 2025684.62%6,582,0911.37%25145.00%33-25.00%18125.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Select Health Care368.99K1.42%-
HBM Healthcare Investments AG Ord415.23K1.41%-
Fidelity Select Biotechnology366.55K1.25%-
Fidelity Growth Company Fund283.34K0.96%-37.00K
Vanguard Total Stock Mkt Idx Inv280.91K0.96%-
Fidelity Advisor Health Care I230.25K0.89%-
iShares Russell 2000 ETF236.79K0.81%1.97K
Fidelity Advisor Biotechnology I167.95K0.66%167.95K
Fidelity Growth Compy Commingled Pl S148.09K0.50%-236.71K
Vanguard US Total Market Shares ETF126.63K0.49%-

Recent Insider Transactions

DateNameRoleActivityValue
Jan 06, 2026Brunn Carsten President and CEOSell$162.08K
Jan 06, 2026Miljkovic Milos Chief Medical OfficerSell$24.37K
Jan 06, 2026Davis Blaine Chief Financial OfficerSell$72.23K
Dec 04, 2025BARABE TIMOTHY C-Buy$205.80K
Apr 11, 2025SPRINGER TIMOTHY A Buy$69.07K

Insider Transactions Trends

DateBuySell
2026 Q1-3
2025 Q41-
2025 Q210-
2025 Q1612
2024 Q42017

RNAC Ownership FAQ

Who Owns Cartesian Therapeutics?

Cartesian Therapeutics shareholders are primarily institutional investors at 27.53%, followed by 53.68% insiders and 18.79% retail investors. The average institutional ownership in Cartesian Therapeutics's industry, Biotech Stocks , is 35.75%, which Cartesian Therapeutics falls below.

Who owns the most shares of Cartesian Therapeutics?

Cartesian Therapeutics’s largest shareholders are Squarepoint ops (2.24M shares, 8.62%), Fmr (799.74K shares, 3.08%), and Blackrock funding, inc. /de (599.11K shares, 2.31%). Together, they hold 14.00% of Cartesian Therapeutics’s total shares outstanding.

Does Blackrock own Cartesian Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cartesian Therapeutics.

Who is Cartesian Therapeutics’s biggest shareholder by percentage of total assets invested?

Bioimpact capital is Cartesian Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.64% of its assets in 380K Cartesian Therapeutics shares, valued at 3.88M$.

Who is the top mutual fund holder of Cartesian Therapeutics shares?

Fidelity Select Health Care is the top mutual fund holder of Cartesian Therapeutics shares, with 1.42% of its total shares outstanding invested in 368.99K Cartesian Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools